Global Digital Therapeutics Market: Regional Insights
Based on geography, the global digital therapeutics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Among regions, North America is expected to gain highest share in the market during the forecast period owing to the rise in incidence of chronic diseases, increasing adoption of digital healthcare, and outbreak of COVID-19 (pandemic) in the region. For instance, research has shown that digital therapeutics solutions for the disease management can drive better outcomes for people living with chronic diseases. According to the U.S. Centers for Disease Control & Prevention (CDC), chronic diseases, such as cardiovascular diseases, cancer, and diabetes, are the leading causes of death and disability in the United States.
Europe and Asia Pacific are also expected to witness significant growth in the digital therapeutics market due to the increasing prevalence of chronic diseases, rise in adoption of digital healthcare, increasing penetration of Internet and smartphone, and outbreak of COVID-19 (pandemic) in these regions. For instance, several European countries, such as France and Belgium, are in a process of evaluating the use/regulation of digital therapeutics, with Germany spearheading these advances, as it has created a pathway, called DiGA, for doctors to prescribe digital therapeutics to publicly-insured patients and receive reimbursement in the same way as a traditional treatment.
Figure 1. Global Digital Therapeutics Market Share (%), by Region, 2023
Based on geography, the global digital therapeutics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Digital Therapeutics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients